Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016

BACKGROUND: Despite evidence shown of dolutegravir (DTG)-related neurotoxicity, which may be more common when combined with abacavir (ABC), its reversibility has not been explored in a clinical trial. METHODS: We conducted a randomized, multicenter, open-label, pilot trial to evaluate the reversibil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Perez Valero, Ignacio, Cabello, Alfonso, Ryan, Pablo, De La Fuente-Moral, Sara, Santos, Ignacio, Vivancos, Maria Jesus, Gonzalez, Alicia, Gorgolas, Miguel, Cuevas, Guillermo, Diaz De Santiago, Alberto, Cano, Joanna, Rua, Guadalupe, Yllescas, Maria, González García, Juan Julian
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727346/
https://ncbi.nlm.nih.gov/pubmed/33335931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa482
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados